Aspirin on par with dalteparin in preventing VTE after hip replacement

06/4/2013 | Medscape (free registration)

Aspirin performed comparably to dalteparin in preventing venous thromboembolism following total hip arthroplasty, according to a 778-patient study in the Annals of Internal Medicine. There were no major bleeding events in the group given aspirin, while there was one case in the dalteparin group. Clinically significant nonmajor bleeding and minor bleeding were reported more often in the dalteparin group than the aspirin group.

View Full Article in:

Medscape (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC